Investigators and Programs

Each investigator is involved in specific fields of endocrine research and each may supervise fellows:

E. Dale Abel, MD, PhD, Mechanisms of cardiac dysfunction in diabetes
Christopher Adams, MD, PhD, Basic studies on muscle metabolism
Joseph S. Dillon, MD, Clinical studies on therapy of carcinoid and neuroendocrine tumors
Thomas M. O'Dorisio, MD, Clinical studies on therapy of carcinoid and neuroendocrine tumors
Amal Shibli-Rahhal, MD, MS, Clinical studies on bone diseases
Janet A. Schlechte, MD, Clinical studies on bone and pituitary diseases
William I. Sivitz, MD, Basic studies on mitochondrial metabolism and its role in diabetes and obesity; Clinical studies in the therapy and pathophysiology of diabetes and obesity
Mark A. Yorek, PhD, Basic studies in neurovascular complication of diabetes and obesity

There is also active clinical and research participation by faculty in other clinical and basic science departments throughout the university focused on issues that relate directly to endocrinology. Fellows are encouraged to pursue training with these individuals outside of the Division of Endocrinology if that fulfills a critical training goal for the individual. Examples of such faculty include but are not limited to the following:

Basic mechanisms of hormone action
Mario Ascoli, PhD, Deborah L. Segaloff, PhD, Rory Fisher, PhD

Vascular function in obesity and diabetes
Frank Faraci, PhD, Curt Sigmund, PhD

Endocrine neoplasia
Ronald Weigel, MD, PhD, James Howe, MD, M. Sue O’Dorisio, MD, PhD

Intensive insulin therapies in children with type 1 diabetes
Eva Tsalikian, MD, Michael Tansey, MD

Developmental origins of metabolic disease
Andrew Norris, MD, PhD

Neuroendocrine mechanisms of obesity
Kamal Rahmouni, PhD

See also faculty of the Diabetes Research Center and Obesity Research and Educational Initiative.